Copyright: ©Author(s) 2026.
World J Gastroenterol. Jul 21, 2026; 32(27): 118071
Published online Jul 21, 2026. doi: 10.3748/wjg.118071
Published online Jul 21, 2026. doi: 10.3748/wjg.118071
Figure 3 Elevated kinetochore-associated protein 1 expression is associated with worse outcomes.
A-C: Kaplan-Meier survival curves showing overall survival, progression-free survival and post-progression survival based on varying kinetochore-associated protein 1 expression levels; D-F: Forest plots summarized the association between kinetochore-associated protein 1 expression and prognosis across different clinical parameters. OS: Overall survival; FP: Progression-free; PPS: Post-progression survival; KNTC1: Kinetochore-associated protein 1; HR: Hazard ratio; CI: Confidence interval.
- Citation: Li YF, Weng CY, Wang M. Kinetochore-associated protein 1 as a prognostic biomarker in gastric cancer: Integrative bioinformatics and experimental validation. World J Gastroenterol 2026; 32(27): 118071
- URL: https://www.wjgnet.com/1007-9327/full/v32/i27/118071.htm
- DOI: https://dx.doi.org/10.3748/wjg.118071